British Columbia Drug and Poison Information Centre (BC DPIC)
Healthcare Professionals
Health Headlines
Weblinks
About DPIC
Contact
Index
Log in
Search this site:
Poison Information
24-Hour Line:
1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
General Information
Prevention Tips
Prevention Material
Fact Sheets
BC Poison Control
Springtime Hazards
Holiday Hazards
Poison FAQ
Antidote Stocking Guidelines
UPDATED
Opioid Guidelines
Poison Management Manual
Drug Information
Drug Information Line
for BC Healthcare Professionals Only
1-866-298-5909 or
604-707-2787
(Mon - Fri, 9am to 4pm)
Clinical Practice Guidelines
Drug Product Listings
Safe Medication Use
Adverse Reaction Reporting
DI Perspectives Newsletter
Drug Desk Newsletter
Home
›
Drug Product Listings
› Vemurafenib
Vemurafenib
Trade Name:
Zelboraf
Manufacturer/Distributor:
Hoffman-La Roche Ltd.
www.rochecanada.com 1-888-762-4388
Classification:
Protein kinase inhibitor
ATC Class:
L01XE15 - Vemurafenib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2012/02/15
Date Marketed in Canada (yyyy/mm/dd):
2012/03/06
Presentation:
Tablet: 240 mg. DIN: 02380242
Comments:
Indicated as monotherapy for the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma. Should only be prescribed and supervised by a qualified physician experienced in the use of anti-cancer agents.
-
A
+
A
Follow DPIC
Facebook
Twitter
Take the DPIC Caller Satisfaction Survey